Cargando…
Engineered Carbonic Anhydrase VI-Mimic Enzyme Switched the Structure and Affinities of Inhibitors
Secretory human carbonic anhydrase VI (CA VI) has emerged as a potential drug target due to its role in pathological states, such as excess acidity-caused dental caries and injuries of gastric epithelium. Currently, there are no available CA VI-selective inhibitors or crystallographic structures of...
Autores principales: | Kazokaitė, Justina, Kairys, Visvaldas, Smirnovienė, Joana, Smirnov, Alexey, Manakova, Elena, Tolvanen, Martti, Parkkila, Seppo, Matulis, Daumantas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722136/ https://www.ncbi.nlm.nih.gov/pubmed/31481705 http://dx.doi.org/10.1038/s41598-019-49094-0 |
Ejemplares similares
-
Intrinsic Thermodynamics and Structure Correlation of Benzenesulfonamides with a Pyrimidine Moiety Binding to Carbonic Anhydrases I, II, VII, XII, and XIII
por: Kišonaitė, Miglė, et al.
Publicado: (2014) -
An update on anticancer drug development and delivery targeting carbonic anhydrase IX
por: Kazokaitė, Justina, et al.
Publicado: (2017) -
Switching the Inhibitor‐Enzyme Recognition Profile via Chimeric Carbonic Anhydrase XII
por: Smirnovienė, Joana, et al.
Publicado: (2021) -
4-Amino-substituted Benzenesulfonamides as Inhibitors of Human Carbonic Anhydrases
por: Rutkauskas, Kęstutis, et al.
Publicado: (2014) -
Saccharin Sulfonamides as Inhibitors of Carbonic Anhydrases I, II, VII, XII, and XIII
por: Morkūnaitė, Vaida, et al.
Publicado: (2014)